GSK to introduce Infanrix DTPa vaccine in Korea

GlaxoSmithKline Korea said that Infanrix DTPa vaccine, which has been widely used all over the world, will be launched in domestic market from June 23 after fulfilling necessary procedures such as state-run tests and packaging work.

A GSK official noted that Infanrix was officially registered in Korea on March this year and will be directly marketed by GSK without the sales route of Korea Gr...